Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment
Julia Brotherton(Canadian Institutes of Health Research), Dorothy A. Machalek(Canadian Institutes of Health Research), Gary M. Clifford(Centre international de recherche sur le cancer), John Kaldor(UNSW Sydney), Miriam Elfström(Karolinska University Hospital), Cosette M. Wheeler(University of New Mexico), Marion Saville(University of Melbourne)
Cited by 20
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
|British Journal of Cancer|2003|1.6k